SELECT trial post hoc reveals surprising knock-on benefit from semaglutide In the SELECT trial, semaglutide (Wegovy and Ozempics active ingredient) reduced cardiovascular death and all-cause mortality among 17,604 enrolled patientsan impressive finding that revealed the drugs potential not just for weight loss, but for control of chronic diseases associated with obesity
Happy with the results but as I start increasing dosage
In one large study involving over 160,000 non-diabetic adults with obesity, researchers found that women prescribed GLP-1 medications had a higher rate of medically diagnosed acne compared to those who were not using these drugs
Example The price of your medicine is $100
Conditions such as vitamin deficiencies, medication interactions, or unrelated oral or neurological conditions can cause taste disturbances and should be considered in the differential diagnosis
Its impressive results have been turning heads, outperforming many established medications